X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7704) 7704
Conference Proceeding (9) 9
Magazine Article (6) 6
Book / eBook (3) 3
Dissertation (3) 3
Book Chapter (2) 2
Publication (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6726) 6726
hepacivirus - physiology (4133) 4133
hepacivirus - genetics (3078) 3078
hepatitis c virus (2974) 2974
male (2000) 2000
hepatitis c (1981) 1981
female (1928) 1928
virology (1779) 1779
middle aged (1625) 1625
hepacivirus - drug effects (1600) 1600
adult (1523) 1523
infection (1478) 1478
gastroenterology & hepatology (1439) 1439
hepatitis c - virology (1410) 1410
animals (1354) 1354
virus diseases (1213) 1213
biochemistry & molecular biology (1201) 1201
virus replication (1189) 1189
cell line (1160) 1160
viruses (1154) 1154
hepatitis (1150) 1150
replication (1082) 1082
antiviral agents - therapeutic use (1072) 1072
hcv (1067) 1067
health aspects (1027) 1027
rna (1018) 1018
antiviral agents - pharmacology (984) 984
genotype (963) 963
immunology (869) 869
hepacivirus - immunology (848) 848
interferon (846) 846
liver (819) 819
digestive system diseases (802) 802
aged (781) 781
cell line, tumor (777) 777
hepatitis c, chronic - drug therapy (769) 769
viral nonstructural proteins - metabolism (767) 767
hepatitis c - drug therapy (759) 759
molecular sequence data (753) 753
virus replication - drug effects (738) 738
infectious diseases (723) 723
hepatitis c, chronic - virology (713) 713
hepacivirus - isolation & purification (673) 673
hepacivirus - metabolism (665) 665
analysis (661) 661
microbiology (656) 656
expression (650) 650
proteins (625) 625
infections (609) 609
rna, viral - genetics (609) 609
hepacivirus (593) 593
base sequence (571) 571
antiviral agents (565) 565
hepacivirus - pathogenicity (561) 561
rna, viral - blood (555) 555
interferon-alpha - therapeutic use (552) 552
hepatocytes - virology (548) 548
ribavirin (536) 536
core protein (524) 524
hepatitis c - complications (514) 514
hepatitis-c virus (510) 510
treatment outcome (504) 504
identification (494) 494
hepatitis c - immunology (484) 484
hepacivirus - enzymology (482) 482
drug therapy, combination (474) 474
viral load (466) 466
ribavirin - therapeutic use (463) 463
viral nonstructural proteins - genetics (462) 462
research (457) 457
genetic aspects (440) 440
research article (438) 438
mice (433) 433
amino acid sequence (424) 424
hepatocellular-carcinoma (412) 412
gastroenterology and hepatology (410) 410
transplantation (396) 396
rna replication (372) 372
biological response modifiers (371) 371
chemistry, medicinal (368) 368
cell biology (361) 361
in-vitro (359) 359
multidisciplinary sciences (358) 358
therapy (358) 358
antiviral agents - chemistry (347) 347
liver - virology (336) 336
hepatitis c - metabolism (335) 335
viral nonstructural proteins - antagonists & inhibitors (335) 335
cells, cultured (331) 331
hepatitis c - genetics (323) 323
gene expression (320) 320
protein binding (315) 315
rna, viral - analysis (310) 310
risk factors (307) 307
rna, viral - metabolism (301) 301
cells (291) 291
binding (288) 288
liver - pathology (287) 287
chemistry, organic (283) 283
surgery (278) 278
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7565) 7565
Japanese (132) 132
Chinese (67) 67
French (45) 45
Russian (33) 33
Spanish (24) 24
Polish (12) 12
German (9) 9
Portuguese (7) 7
Hungarian (2) 2
Korean (2) 2
Italian (1) 1
Norwegian (1) 1
Romanian (1) 1
Serbian (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2011, Volume 56, Issue 4, pp. 803 - 809
Background & Aims Hepatitis C virus (HCV) causes progressive liver disease and is a major risk factor for the development of hepatocellular carcinoma (HCC).... 
Gastroenterology and Hepatology | Hepatitis C | Hypoxia | Invasion | ANGIOGENESIS | HEPATOCELLULAR-CARCINOMA | HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA | MESENCHYMAL TRANSITIONS | GROWTH | INFECTION | RECURRENCE | GASTROENTEROLOGY & HEPATOLOGY | CELL ENTRY | EXPRESSION | Carcinoma, Hepatocellular - physiopathology | Humans | Transforming Growth Factor beta - physiology | Glycoproteins - physiology | Cell Movement - physiology | Disease Progression | Tight Junctions - physiology | Carcinoma, Hepatocellular - pathology | Liver Neoplasms - physiopathology | Cell Line, Tumor | Cell Polarity - physiology | Hepacivirus - physiology | Hepatitis C - physiopathology | Liver Neoplasms - pathology | Hepatitis C - pathology | Hypoxia-Inducible Factor 1, alpha Subunit - physiology | Vascular Endothelial Growth Factor A - physiology | Virus Replication - physiology | TGFβ, transforming growth factor-beta | PHH, primary human hepatocytes | VEGF, vascular endothelial growth factor | EMT, epithelial to mesenchymal transition | TNFα, tumor necrosis factor alpha | BC, bile canaliculi | JFH-1, Japanese fulminant hepatitis-1 | MRP-2, multidrug resistant protein-2 | HIF-1α, hypoxia inducible factor 1 alpha | HCVcc, hepatitis C virus cell culture | HCC, hepatocellular carcinoma | SR-BI, scavenger receptor class B member 1 | CMFDA, 5-chloromethylfluorescein diacetate | VSV-G, vesicular stomatitis virus glycoprotein
Journal Article